Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Shionogi & Co Ltd Deals'
Title Publication Date Price Relevance
Shionogi & Co., Ltd.-Deals & Alliances Report Mar 2011 £380 100%
Shionogi & Co., Ltd. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
 Jul 2009 £160 99%
Premature Ejaculation - Pipeline Review
H2 2011
 Sep 2011 £315 77%
Premature Ejaculation (PE) Therapeutics
Pipeline Assessment and Market Forecasts to 2017
 Jul 2011 £1,265 72%
Hypertension - Pipeline Review
H2 2011
 Sep 2011 £315 72%
Solid Tumor - Pipeline Review
H1 2012
 Jan 2012 £325 72%
Esophageal Cancer - Pipeline Review
H1 2012
 Jan 2012 £325 72%
Thrombocytopenia - Pipeline Review
H2 2011
 Sep 2011 £315 72%
Cancer Pain - Pipeline Review
H2 2011
 Oct 2011 £315 71%
Cancer Pain Therapeutics
Pipeline Assessment and Market Forecasts to 2017
 Apr 2011 £1,265 70%
Allergic Rhinitis - Pipeline Review
H2 2011
 Sep 2011 £315 70%
Rhinitis - Pipeline Review
H2 2011
 Sep 2011 £315 70%
Asthma - Pipeline Review
H2 2011
 Sep 2011 £315 70%
Urinary Tract Cancer - Pipeline Review
H1 2012
 Jan 2012 £325 68%
Addiction – Pipeline Review
H2 2011
 Dec 2011 £315 68%
Influenza - Pipeline Review
H2 2011
 Sep 2011 £315 68%
Male Sexual Dysfunction - Pipeline Review
H2 2011
 Aug 2011 £315 67%
Bladder Cancer - Pipeline Review
H2 2011
 Sep 2011 £315 67%
Hypertension - Pipeline Review
Q1 2011
 Feb 2011 £315 66%
Obesity - Pipeline Review
H2 2011
 Sep 2011 £315 66%
Type 2 Diabetes - Pipeline Review
H2 2011
 Sep 2011 £315 66%
Anti-Hypertensive Drugs Feb 2010 £2,500 66%
Opium Addiction - Pipeline Review
H2 2011
 Oct 2011 £315 64%
Diabetes - Pipeline Review
H2 2011
 Oct 2011 £315 64%
Cardiovascular Drugs Apr 2010 £2,815 64%
Japan in Vitro Diagnostics Investment Opportunities
Analysis and Forecasts to 2015
 Apr 2009 £1,580 58%
Acute Coronary Syndrome Apr 2010 £2,180 56%
Sarcomas - Pipeline Review
Q3 2011
 Jul 2011 £315 55%
The World Antibacterial Treatments Market
2010-2024
 Dec 2009 £1,499 55%
The Outlook for Pharmaceuticals in North East Asia Nov 2011 £1,995 55%